ESTHETIK MED

Active

Private limited companyfounded 2016active for 10 yearsRue Grande 154, 7020 Mons, BelgiumKBO/BCE: BE 0651.954.321

Summary

The computed 12-month bankruptcy probability of ESTHETIK MED is 1.5% (moderate). The 2025 annual accounts show negative equity (-€160,747) and a net result of -€7,472. Equity is shrinking by about 10% per year across the filed financial years. Its solvency ranks better than 5% of 22,595 sector peers (NACE 47, financial year 2025). The company has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

ESTHETIK MEDActiveChecked score 53/100

Risk analysis Report Compare

Activity

Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses

NACE 47741

1 site

Size

€13,739total assets 2025

Equity: -€160,747
Loss: -€7,472

Turnover not published (micro format)

Financial health

53 Fair Checked score 2025

Bankruptcy probabilitywithin 12 months: 1.5%

Structure

Monique ABRASSARTDirector

2025 accounts 4 days early1 of 3 deeds summarised

Why 53raises riskCapped at 59: negative equityLoss of €7,472, the second in a row (financial year 2025)Negative equity -€160,747Sector: Retail trade (NACE 47)lowers riskSize: total assets €13,739Show the evidence

Checked score

Score 2025

53 / 100

Fair

Probability in this band: 1.5% to 4.2%

Financially better than 12% of its sector peers (NACE 47, micro)

Negative equity caps the score at 59. Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Weak

Solvency 0=

equity -1170.0% of total assets

Liquidity 0-2

short-term debt 1270.0% · cash 0.4%

Profitability 0=

return on assets -54.4%

Bankruptcy probability, 12 months

1.5% Moderate

0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,248 companies, NACE 47, micro)

Last 24 months 11-2024: 1.5% 12-2024: 1.4%▼ -0.1 percentage points vs 11-2024lowest value 01-2025: 1.6%▲ +0.2 percentage points vs 12-2024 02-2025: 1.5%▼ -0.1 percentage points vs 01-2025 03-2025: 1.5%● unchanged vs 02-2025 04-2025: 1.5%● unchanged vs 03-2025 05-2025: 1.5%● unchanged vs 04-2025 06-2025: 1.5%● unchanged vs 05-2025 07-2025: 1.5%● unchanged vs 06-2025 08-2025: 1.5%● unchanged vs 07-2025 09-2025: 1.5%● unchanged vs 08-2025 10-2025: 1.6%▲ +0.1 percentage points vs 09-2025 11-2025: 1.5%▼ -0.1 percentage points vs 10-2025 12-2025: 1.5%● unchanged vs 11-2025 01-2026: 1.7%▲ +0.2 percentage points vs 12-2025 02-2026: 2.0%▲ +0.3 percentage points vs 01-2026highest value 03-2026: 1.6%▼ -0.4 percentage points vs 02-2026 04-2026: 1.6%● unchanged vs 03-2026 05-2026: 1.6%● unchanged vs 04-2026 06-2026: 1.6%● unchanged vs 05-2026 07-2026: 1.6%● unchanged vs 06-2026 08-2026: 1.6%● unchanged vs 07-2026 09-2026: 1.6%● unchanged vs 08-2026 10-2026: 1.5%▼ -0.1 percentage points vs 09-2026

No credit on open account

Liquidity insufficient (current ratio 0.02, compared with 0.01 in 2024, below 1; cash: 0.4% of total assets), and equity is negative.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 6% on solvency, 2% on liquidity, 6% on profitability and 31% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Size: total assets €13,739

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Loss of €7,472, the second in a row (financial year 2025)

NBB · annual accounts

Negative equity -€160,747

NBB · annual accounts

Sector: Retail trade (NACE 47)

KBO

Negative equity

The 2025 annual accounts show negative equity and a net loss.

NBB · annual accounts 2025

Equity per financial year

19202122232425

2019 to 2025 · latest year -€160,747

Latest accounts filed on time

The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 27-01-2026, 4 days ahead of the deadline.

NBB · 9 filings

Deviation from the deadline

2025

4 days early

2024

18 days early

2023

1 day early

2022

1 day early

2021

17 days late

2020

27 days late

2019

465 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 69 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 30 January (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-06-2026 year end28-10-2026 today31-01-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

27-01-2026 Annual accounts filedfinancial year 2025 · micro…
13-01-2025 Annual accounts filedfinancial year 2024 · micro…
05-04-2024 Resignation: Monique ABRASSART (statutory manager)Appointment: Monique ABRASSART (statutory director)…

Key points

Risk: Negative equityfinancial year 2025: debts exceed assets -€160,747 View
Risk: 7 loss-making years in a rowloss financial year 2025 -€7,472 View
Caution: Among the weakest 5% on solvencysector median 33.3% · 22,595 companies -1170.0% View
Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

By topic

Financials

Financial year: 2025
Total assets: €13,739
Loss: -€7,472
Solvency: -1170.0%

Total assets▲ 99.8%

Net result

20192025

Go to Financials

Board & ownership

Board: 1 member

Monique ABRASSARTDirector

Go to Board & ownership

Timeline

Events: 10
Since: 2017
Next accounts: by 31-01-2027

30-01-2024Annual accounts filed
30-01-2023Annual accounts filed
17-02-2022Annual accounts filed

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: Retail sale of medical and orthopaedic goods, excluding…NACE 47741
Founded: 15-04-2016
Year ends: 30-06
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 26

Annual meeting: First Friday of December
Purpose: “Soin cryothérapie; Réjuvénation cutanée,élimination des poils,le raffermissement de la…” (deed in French)

Go to Articles of association

Key facts about ESTHETIK MED

What is the company number of ESTHETIK MED?: 0651.954.321. In Belgium the VAT number is the company number with BE in front: BE 0651.954.321.
Where is ESTHETIK MED based?: The registered office is at Rue Grande 154, 7020 Mons.Company details
What does ESTHETIK MED do?: According to the KBO register, the main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741).
What is the legal form of ESTHETIK MED?: Private limited company (BV).
When was ESTHETIK MED founded?: On 15-04-2016.
Is ESTHETIK MED still active?: Yes, ESTHETIK MED is an active enterprise in the KBO register.
How many employees does ESTHETIK MED have?: On average 0.3 full-time equivalents in financial year 2020, according to the filed annual accounts.Financials
What is the turnover of ESTHETIK MED?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is ESTHETIK MED profitable?: In financial year 2025, ESTHETIK MED made a loss of €7,472.
Where can I find the annual accounts of ESTHETIK MED?: ESTHETIK MED filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ESTHETIK MED due?: By 31-01-2027, for financial year 2026.Timeline